Avi Leader

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Direct Oral Anticoagulants

Top Venues

Journal of thrombosis and haemostasis : JTH

Journal of thrombosis and thrombolysis

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety (2024)
Ayala Gover-Proaktor, Dorit Leshem-Lev, Sabina Winograd-Katz, Shirly Partouche, Aladin Samara, Saar Shapira, Inbar Nardi-Agmon, Emanuel Harari, Aseel Younis, Abderrahman Najjar, Ran Kornowski, Benjamin Geiger, Pia Raanani, Avi Leader, Galit Granot
Dasatinib induces endothelial dysfunction leading to impaired recovery from ischaemia. British journal of haematology (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Bronya Calvarysky, Idit Dotan, Daniel Shepshelovich, Avi Leader, Talia Diker Cohen
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic Review. Drug safety 47 (5) (2024)
Nicola Potere, Alexandru Grigorean, Isabelle Mahé, Gabriela Cesarman-Maus, Pantep Angchaisuksiri, Avi Leader, Helen C Okoye, Edeghonghon Olayemi, Cihan Ay, Marc Carrier, Jean Marie Connors, Ioannis T Farmakis, Riccardo M Fumagalli, Zhi-Cheng Jing, Lai Heng Lee, Claire McLintock, Fionnuala Ní Áinle, George Giannakoulas, Shinya Goto, Maria Cecilia Guillermo Esposito, Luis Jara Palomares, Marta Szlaszynska, Chee Wee Tan, Nick Van Es, Tzu-Fei Wang, Beverley Jane Hunt, Marcello Di Nisio
Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day. Journal of thrombosis and haemostasis : JTH 20 (12) (2022)
Daniela R Anderson, Wendy Stock, Theodore G Karrison, Avi Leader
D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia. Blood advances 6 (17) (2022)
Sarah Sharman Moser, Galia Spectre, Pia Raanani, Orr Friedman-Mazursky, Matanya Tirosh, Gabriel Chodick, Avi Leader
Cancer-associated venous thromboembolism in Israel: Incidence, risk factors, treatment, and health care utilization in a population based cohort study. Research and practice in thrombosis and haemostasis 6 (4) (2022)
Nir Livneh, Dionne Braeken, Genady Drozdinsky, Anat Gafter-Gvili, Jaap Seelig, Uri Rozovski, Tamar Berger, Pia Raanani, Anna Falanga, Hugo Ten Cate, Galia Spectre, Avi Leader
Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy. Journal of thrombosis and thrombolysis 52 (2) (2021)
Tzu-Fei Wang, Lisa Baumann Kreuziger, Avi Leader, Galia Spectre, Ming Y Lim, Andrew Gahagan, Radhika Gangaraju, Kristen M Sanfilippo, Ranjeeta Mallick, Jeffrey I Zwicker, Marc Carrier
Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. Journal of thrombosis and haemostasis : JTH 19 (8) (2021)
Oded Icht, Naama Darzi, Shai Shimony, Oded Jacobi, Daniel Reinhorn, Yosef Landman, Raz Mutai, Itamar Averbuch, Tzippy Shochat, Galia Spectre, Pia Raanani, Ofer Rotem, Elizabeth Dudnik, Nir Peled, Alona Zer, Avi Leader
Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors. Journal of thrombosis and haemostasis : JTH 19 (5) (2021)
Avi Leader, Noa Dagan, Noam Barda, Idan Goldberg, Pia Raanani, Galia Spectre, Ran Balicer, Anat Gafter-Gvili
Previously undiagnosed cancer in patients with arterial thrombotic events - A population-based cohort study. Journal of thrombosis and haemostasis : JTH (2021)
Avi Leader, Liron Hofstetter, Galia Spectre
Challenges and Advances in Managing Thrombocytopenic Cancer Patients. Journal of clinical medicine 10 (6) (2021)
Moshe Mittelman, Ori Magen, Noam Barda, Noa Dagan, Howard S Oster, Avi Leader, Ran Balicer
Effectiveness of the BNT162b2mRNA Covid-19 Vaccine in Patients with Hematological Neoplasms. Blood (2021)